Show
Sort by
-
Evaluation of targeted drugs in combination with the MDM2 antagonist RG7388 in neuroblastoma
-
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients
-
Fecal metabolite profiling as first step towards a fingerprint/biomarker-screening tool for disease assessment
-
Optimalization and characterization of a novel intraductal mouse mammary tumor model
-
SOX11 is a lineage-survival oncogene in neuroblastoma
-
Phf6 plays a role in hematopoiesis and thymopoiesis in zebrafish
-
- Conference Paper
- C3
- open access
The possible role of somatropin derivatives as a theranostic in oncology
-
The MYCN/miR-26a-5p/LIN28B regulatory axis explains MYCN driven LIN28B upregulation during mouse neuroblastoma development
-
Green tea compound EGCG activates HBP1: an ALK downstream suppressor gene in neuroblastoma
-
- Conference Paper
- C3
- open access
Pharmacopeial characterization of asparaginase
-
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in early immature T-cell acute lymphoblastic leukemia
-
Determining the cofactor profile of the glucocorticoid receptor in lymphoid malignancies using MARCoNI
-
In vitro and in vivo screening for diet-related DNA adducts using ultra-high performance liquid chromatography coupled to mass spectrometry
-
Molecular MRI in preclinical research
-
Micro-particle encapsulated carcinoma-associated fibroblast (CAF) deceive and redirect disseminated cancer cells
-
Temporal dynamics and therapeutic potential of the unfolded protein espouse in hepatocellular carcinoma
-
F-18 fluoromethylcholine (FCho), F-18 fluoroethyltyrosine (FET) and F-18 fluorodeoxyglucose (FDG) for the discrimination between tumor recurrence and radiation necrosis in high-grade glioma: a µPET study
-
Cancer-associated adipose tissue promotes breast cancer progression by paracrine Oncostatin M and JAK3/STAT3 signaling